Mezera®

INN: mesalamine

Approved for use in:

Ulcerative Colitis (mild-moderate)

Type/Class

5-aminosalicylic acid (5-ASA)

Delivery Route

Oral (tablet)
Rectal (foam enema, suppository)

Health Canada Approval

Oral: 2022
Rectal: 2018

Storage

Oral: store between 15 and 30°C.
Rectal: store between 15 and 30°C, and away from direct heat, light and humidity.

Use in Older Adults (65+)

Individuals with impaired renal function may be at greater risk of toxic reactions.

Pregnancy Indication

May cause adverse pregnancy outcomes; only use if benefits outweigh risks.

Breastfeeding Indication

Has been detected in breast milk; may cause diarrhea in breastfed infants.

Pediatric Indication

Not authorized.

Learn More

View the Mezera® oral product monograph.
View the Mezera® rectal product monograph.